(S)-3,5-Dihydroxyphenylglycine; 162870-29-3; (S)-3,5-DHPG; S-DHPG; L-3,5-Dihydroxyphenylglycine; (S)-3,5-Dihydroxyphenylglycine hydrate; (2S)-2-amino-2-(3,5-dihydroxyphenyl)acetic acid; C8H9NO4; 3,5-Dihydroxy-L-phenylglycine; Dihydroxyphenylglycine; CHEMBL39221; CF5G2G268A; Benzeneacetic acid, alpha-amino-3,5-dihydroxy-, (alphaS)-; CHEBI:29474; (S)-3,5 DHPG; J516.528H; (2S)-amino(3,5-dihydroxyphenyl)ethanoic acid; (S)-2-amino-2-(3,5-dihydroxyphenyl)acetic acid; CHEBI:75204; (2r)-Amino(3,5-Dihydroxyphenyl)Acetic Acid; Tocris-0342; Tocris-0805; Lopac-D-3689; 3,5-Dihydroxy-phenylglycine; UNII-CF5G2G268A; Lopac0_000328; SCHEMBL12648471; (s)-3,5-dihydroxylphenylglycine; DTXSID20904031; 3,5-DHPG-(S); HMS3261A17; HMS3266F22; HMS3411L21; HMS3675L21; ZINC968043; Dihydroxyphenylglycine, (S)-3,5-; Tox21_500328; BDBM50079183; HB0045; AKOS006239507; amino(3,5-dihydroxyphenyl)acetic acid; CCG-204423; DB04228; LP00328; SDCCGSBI-0050316.P002; NCGC00015338-01; NCGC00015338-02; NCGC00024545-01; NCGC00024800-01; NCGC00024800-02; NCGC00024800-03; NCGC00024800-04; NCGC00024800-05; NCGC00024800-10; NCGC00261013-01; HY-12598; Amino-(3,5-dihydroxy-phenyl)-acetic acid; (2S)-amino(3,5-dihydroxyphenyl)acetic acid; CS-0012064; EU-0100328; (S)-Amino-(3,5-dihydroxy-phenyl)-acetic acid; D 3689; E98655; (S)-2-amino-2-(3,5-dihydroxyphenyl)aceticacid; EN300-3004820; SR-01000075813; SR-01000597444; Amino-(3,5-dihydroxy-phenyl)-acetic acid(S-DHPG); J-009981; SR-01000075813-1; SR-01000597444-1; (alphaS)-alpha-Amino-3,5-dihydroxybenzeneacetic acid; Q27095051; BENZENEACETIC ACID, .ALPHA.-AMINO-3,5-DIHYDROXY-, (.ALPHA.S)-